Conmed Stock Investor Sentiment

CNMD Stock  USD 58.83  0.54  0.93%   
About 55% of CONMED's shareholders are presently thinking to get in. The analysis of overall sentiment of trading CONMED stock suggests that some investors are interested at this time. The current market sentiment, together with CONMED's historical and current headlines, can help investors time the market. In addition, many technical investors use CONMED stock news signals to limit their universe of possible portfolio assets.

Comfort Level 55

 Impartial

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use CONMED's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward CONMED.

CONMED Historical Sentiment

Although CONMED's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding CONMED, such as negative comments on social media and news outlets, may cause fear in the market and push CONMED's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of CONMED.
  

CONMED Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards CONMED can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

CONMED Historical Investor Sentiment

Investor biases related to CONMED's public news can be used to forecast risks associated with an investment in CONMED. The trend in average sentiment can be used to explain how an investor holding CONMED can time the market purely based on public headlines and social activities around CONMED. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
CONMED's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for CONMED and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average CONMED news discussions. The higher the estimate score, the more favorable the investor's outlook on CONMED.
a day ago at news.google.com         
Disposition of 27500 shares by Heather Cohen of CONMED at 59.96 subject to Rule 16b-3
Google News at Macroaxis
2 days ago at news.google.com         
Wealthfront Advisers LLC Makes New Investment in CONMED Co. - MarketBeat
Google News at Macroaxis
3 days ago at news.google.com         
Ex-Dividend Reminder Gilead Sciences, CONMED and Thermo Fisher Scientific - Nasdaq
Google News at Macroaxis
few days ago at finance.yahoo.com         
BD Strongest Q4 Results from the Surgical Equipment Consumables - Diversified Group
Yahoo News
few days ago at simplywall.st         
CONMED Corporation Looks Interesting, And Its About To Pay A Dividend
Simply Wall St News at Macroaxis
few days ago at finance.yahoo.com         
Theres A Lot To Like About CONMEDs Upcoming US0.20 Dividend
Yahoo News
over a week ago at zacks.com         
Conmed Down 12.2 percent Since Last Earnings Report Can It Rebound?
zacks News
over a week ago at finance.yahoo.com         
Disposition of tradable shares by Brent Lalomia of CONMED subject to Rule 16b-3
Yahoo News
over a week ago at finance.yahoo.com         
CONMED Corporation Among the Cash-Rich Small Cap Stocks To Invest In According To Analysts
Yahoo News
over a week ago at insidermonkey.com         
CONMED Corporation Among the Cash-Rich Small Cap Stocks To Invest In According To Analysts
insidermonkey News
over a week ago at finance.yahoo.com         
Conmed Down 12.2 percent Since Last Earnings Report Can It Rebound?
Yahoo News
over a week ago at news.google.com         
Disposition of 1000 shares by Charles Farkas of CONMED at .64 subject to Rule 16b-3
Google News at Macroaxis
over a week ago at finance.yahoo.com         
Global Operating Room Equipment Market is Predicted to Cross USD 40 Billion by 2032 DelveInsight
Yahoo News
over a week ago at www.macroaxis.com         
Acquisition by Peter Shagory of 26127 shares of CONMED at 58.33 subject to Rule 16b-3
Macroaxis News
over two weeks ago at finance.yahoo.com         
CONMED Is Due To Pay A Dividend Of 0.20
Yahoo News
Far too much social signal, news, headlines, and media speculation about CONMED that are available to investors today. That information is available publicly through CONMED media outlets and privately through word of mouth or via CONMED internal channels. However, regardless of the origin, that massive amount of CONMED data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of CONMED news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of CONMED relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to CONMED's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive CONMED alpha.

CONMED Performance against Dow Jones

 Price Growth (%)  
       Timeline  
 
CONMED dividend paid on 3rd of January 2025
01/03/2025
1
Conmed Corp Announces Fourth Quarter 2024 Financial Results Release Date
01/06/2025
2
Acquisition by Moller Andrew James of 5000 shares of CONMED at 71.18 subject to Rule 16b-3
01/27/2025
3
Cardinal Health Surpasses Q2 Earnings and Revenue Estimates
01/30/2025
4
CONMED Cut to Neutral at JPMorgan Chase Co.
02/06/2025
5
Principal Financial Group Inc. Purchases 4,343 Shares of CONMED Co. - MarketBeat
02/21/2025
6
Conmed Corp Declares Quarterly Cash Dividend
02/25/2025
7
Carpal Tunnel Release Systems Market to Exceed US 1,036.4 Million by 2035, Driven by Minimally Invasive Advances and Aging Population Latest Report by Transpare...
02/26/2025
8
CONMED Is Due To Pay A Dividend Of 0.20
02/28/2025
9
Acquisition by Peter Shagory of 26127 shares of CONMED at 58.33 subject to Rule 16b-3
03/03/2025
10
Disposition of 1000 shares by Charles Farkas of CONMED at .64 subject to Rule 16b-3
03/05/2025
11
CONMED Corporation Among the Cash-Rich Small Cap Stocks To Invest In According To Analysts
03/07/2025
12
Wealthfront Advisers LLC Makes New Investment in CONMED Co. - MarketBeat
03/13/2025

Complementary Tools for CONMED Stock analysis

When running CONMED's price analysis, check to measure CONMED's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CONMED is operating at the current time. Most of CONMED's value examination focuses on studying past and present price action to predict the probability of CONMED's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CONMED's price. Additionally, you may evaluate how the addition of CONMED to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
CEOs Directory
Screen CEOs from public companies around the world